HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ulta Beauty Surge Continues: Little Sign Of Trade-Down Or Dampened Consumer Appetites Yet

Executive Summary

The retailer increased its full-year targets on 25 August based on broad-based, double-digit growth across its business.

You may also be interested in...



Natural, Low-Maintenance Makeup Trends Shaping Global Beauty In New Year – Euromonitor

The COVID-19 pandemic and related austerities may be past, but makeup is still not back, according to Euromonitor. There is opportunity, however, for multi-purpose, benefit-focused cosmetics that support skin health and the natural-beauty appearance consumers cultivated during the pandemic. Additional views from Kline & Company, Mintel, NPD Group.

Prestige Beauty Lines Ring In Holiday Season Riding Sales Growth, Reining In Price Increases

Prestige beauty sales should be strong through year-end with high-income consumer base less likely to feel squeeze of inflation, NPD Group forecasts. In 2022 first half, US consumers with more than $100,000 household incomes spent nearly $9bn on beauty products, a 14% increase.

Ulta Elevates Clean Beauty With Certification Program, Ingredient Standard

Conscious Beauty, launching at Ulta in the fall, is built around five pillars for product certification – clean ingredients, cruelty free, vegan, sustainable packaging and positive impact. Clean ingredients means no parabens, phthalates or listed ingredients in 25 other categories, the retailer says.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS152871

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel